Evidence map›Paper›PMID 30935091›Full record

ReviewInternational journal of molecular sciences2019

HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons.

Jonathan Iaconelli, Lucius Xuan, Rakesh Karmacharya

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Intepirdine Derivatives Possessing Dual 5HT6 Antagonism / HDAC6 Inhibitory Activity.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jonathan IaconelliCenter for Genomic Medicine, Harvard Medical School and Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA. jiaconel@scripps.edu.
Lucius XuanCenter for Genomic Medicine, Harvard Medical School and Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA. lxuan@partners.org.
Rakesh KarmacharyaCenter for Genomic Medicine, Harvard Medical School and Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA. karmacharya@mgh.harvard.edu.ORCID 0000-0002-0565-5482
Broad Institute · US

Funding

Ex vivo signature of psychosis and treatment response in patient-derived neuronsR01MH113858 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI KARMACHARYA, RAKESH · 2017 to 2021
$2.7M
Wnt/GSK3/beta Catenin Signaling as a Target for Treatment of Bipolar DisorderK08MH086846 · NIMH · MCLEAN HOSPITAL · PI KARMACHARYA, RAKESH · 2010 to 2014
$901k
Doris Duke Charitable Foundation 2015088National Institute of Mental Health MH086846National Institute of Mental Health MH113858NIMH NIH HHS K08 MH086846NIMH NIH HHS R01 MH113858Ryan Licht Sang Bipolar Foundation 2013Steve Willis and Elissa Freud MGH2012
6 · The paper itself

Abstract

Recent studies show that histone deacetylase 6 (HDAC6) has important roles in the human brain, especially in the context of a number of nervous system disorders. Animal models of neurodevelopmental, neurodegenerative, and neuropsychiatric disorders show that HDAC6 modulates important biological processes relevant to disease biology. Pan-selective histone deacetylase (HDAC) inhibitors had been studied in animal behavioral assays and shown to induce synaptogenesis in rodent neuronal cultures. While most studies of HDACs in the nervous system have focused on class I HDACs located in the nucleus (e.g., HDACs 1,2,3), recent findings in rodent models suggest that the cytoplasmic class IIb HDAC, HDAC6, plays an important role in regulating mood-related behaviors. Human studies suggest a significant role for synaptic dysfunction in the prefrontal cortex (PFC) and hippocampus in depression. Studies of HDAC inhibitors (HDACi) in human neuronal cells show that HDAC6 inhibitors (HDAC6i) increase the acetylation of specific lysine residues in proteins involved in synaptogenesis. This has led to the hypothesis that HDAC6i may modulate synaptic biology not through effects on the acetylation of histones, but by regulating acetylation of non-histone proteins.

Indexed as

Cell DifferentiationHippocampusHistone Deacetylase 6Histone Deacetylase InhibitorsHumansNeuronsSignal TransductionHistone Deacetylase 6Histone Deacetylase InhibitorsacetylationAKTHDAC6HDAC inhibitorneuronal differentiationsynapseβ-catenin

Identifiers

PMID30935091
PMCPMC6480207
OpenAlexW2934052433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.